Sunshine Isn't Enough: Time for Change in Industry/Prescriber Relationships
This article was originally published in RPM Report
Pharmaceutical companies understandably feel that critics of their marketing practices don’t always tell the whole story. But they cannot afford to ignore consumer attitudes about their relationships with providers. Consumers are sending a clear message: Sunshine isn’t enough; the relationships need to change.
You may also be interested in...
Orthopedic device manufacturers are out ahead of the drug industry in adapting to new payment disclosure laws. One company, Stryker, has embraced the requirement wholeheartedly and may have found a way to make the listing a benefit to doctors and patients.
Medicare led the way to create a policy that’s just plain mean. Is there any way back?
The health reform law lists prescription drugs as one of the 10 categories that plans must include as essential benefits. Decisions on which medicines, how many, and, perhaps most importantly, at what cost to the patient are all questions that HHS needs to determine.